• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Apply for the Fierce AI Innovation Awards - Submissions close Thursday, June 18
red light green light
Biotech

UniQure stock surges after FDA U-turn clears path to filing

The FDA gave the biotech the OK to file for accelerated approval after previously demanding data from another trial.
Nick Paul Taylor Jun 17, 2026 9:10am
Jazzs palm tree ASCO display

Jazz, AbCellera strike TCE discovery and development deal

Jun 17, 2026 7:00am
How NECs AI and oral delivery system are redefining personalized cancer therapy

How NEC's AI and oral delivery system are redefining personalized cancer therapy

Brought to you by NEC Bio
Migraine headacheepilepsy brain image

Vedana surfaces with $46M to develop migraine prevention therapies

Jun 17, 2026 9:48am
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Triveni Bio & more

Jun 17, 2026 9:30am
2026 with glowing coin and dollar sign
Favicon Fierce Pharma

PwC projects continued growth for rest of 2026, fueled by M&A

Jun 17, 2026 5:00am
More News

FDA appears less prickly toward Moderna mRNA flu shot

Jun 16, 2026 2:46pm

Lilly buys 4E to beef up its non-opioid pain pipeline

Jun 16, 2026 2:34pm

Altaris scoops up AI drug development outfit for $375M

Jun 16, 2026 12:13pm

Edgewise data power rival to BMS and Cytokinetics toward phase 3

Jun 16, 2026 10:39am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings